38 completed, 10 unknown, 4 not yet recruiting, 3 terminated. 19 Phase 4, 15 Not applicable, 9 Phase 1, 7 Phase 3, 4 Phase 2.
Follow Amisulpride: new trials by email Literature Review of Amisulpride trials Research Report on Amisulpride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery Amisulpride, Ondansetron - PONV | Not applicable | Not yet recruiting | Qianfoshan Hospital | 718 | 2026-11-15 | 2026-10-23 |
| Sequential Treatment Approaches for Treatment-Resistant Schizophrenia [Phase 1] Clozapine, [Phase 1] Aripiprazole, [Phase 1] Amisulpride - Treatment-resistant Schizophrenia | Phase 3 | Recruiting | Shanghai Mental Health Center | 300 | 2026-09-01 | 2026-11-05 |
| Application of Multimodal Intervention in the Prevention of Postoperative Nausea and Vomiting After Gynecological Laparoscopic Surgery Amisulpride Injection, Dexamethasone (intravenous), Transcutaneous electrical acupoint stimulation (TEAS) - Nausea and Vomiting, Postoperative | Not applicable | Not yet recruiting | Sir Run Run Shaw Hospital | 212 | 2026-07-01 | 2026-06-08 |
| Amisulpride for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery Tropisetron - PONV | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 526 | 2026-05-10 | 2026-04-28 | |
| Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings Amisulpride, Placebo - Drug Liking | Early Phase 1 | Not yet recruiting | Stanford University | 100 | 2026-03-01 | 2026-01-16 |
| Magnetic Seizure Therapy for Psychotic Disorders Magnetic seizure therapy by Magnetic stimulator, Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc) - Psychotic Disorders | Not applicable | Recruiting | Shanghai Jiao Tong University School of Medicine | 50 | 2024-09-01 | 2025-11-25 |
| Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients Amisulpride Injection, Dexamethasone - Nausea and Vomiting, Postoperative | Phase 2 / Phase 3 | Completed | Acacia Pharma Ltd | 453 | 2024-01-18 | 2025-06-25 |
| An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms Amisulpride 50 MG - Schizophrenia, Treatment-Resistant | Not applicable | Withdrawn | University of California, Los Angeles | 2023-11-01 | 2024-06-24 | |
| Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd. - Bioequivalence, Schizophrenia | Phase 1 | Unknown | The Affiliated Hospital of Qingdao University | 100 | 2023-09-20 | 2023-10-04 |
| A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV. Amisulpride, Amisulpride Placebo - PONV | Phase 3 | Unknown | Qilu Pharmaceutical (Hainan) Co., Ltd. | 516 | 2023-04-29 | 2023-04-21 |
| Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment Rescue Post-Operative Nausea and Vomiting (PONV) treatment according to the standard of care (SOC), Amisulpride - Nausea and Vomiting, Postoperative | Withdrawn | Acacia Pharma Ltd | 2022-11-01 | 2023-04-07 | ||
| Effects of a Single Dose of Amisulpride on Functional Brain Changes Amisulpride Pill, Placebo - Major Depressive Disorder | Phase 1 | Completed | Simone Grimm | 127 | 2022-05-17 | 2023-11-24 |
| Psychobiological Mechanisms Underlying Chronic Pain Bromocriptine Mesylate Capsules, Amisulpride 400 MG, Placebo - Fibromyalgia, Pain, Chronic | Not applicable | Completed | susanne becker | 48 | 2021-11-01 | 2023-09-07 |
| PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment Amisulpride IV, Amisulpride Oral Tablet - Renal Disease, End Stage | Phase 1 | Completed | Acacia Pharma Ltd | 12 | 2021-06-03 | 2021-12-13 |
| Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building Risperidone, Aripiprazole, Ziprasidone - Schizophrenia | Phase 4 | Unknown | Shanghai Mental Health Center | 350 | 2021-05-01 | 2020-08-26 |
| Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis Clozapine, haloperidol, pimozide, olanzapine, risperidone, amisulpride - Psychosis, Intellectual Disability | Phase 2 | Unknown | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 75 | 2020-11-26 | 2024-03-20 |
| Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa amisulpride, bromocriptine, Placebo - Anorexia Nervosa | Early Phase 1 | Completed | University of California, San Diego | 31 | 2020-10-20 | 2025-04-11 |
| Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia Amisulpride - Negative Symptom, Schizophrenia | Early Phase 1 | Unknown | Shanghai Mental Health Center | 6 | 2020-10-01 | 2020-09-01 |
| Amisulpride Treatment for BPSD in AD Patients Amisulpride, Olanzapine - BPSD, Amisulpride | Not applicable | Unknown | Tianjin Anding Hospital | 76 | 2019-12-01 | 2022-11-16 |
| Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression Amisulpride, Olanzapine-Fluoxetine Combination - Post-Schizophrenic Depression | Phase 4 | Completed | All India Institute of Medical Sciences, Bhubaneswar | 60 | 2019-10-14 | 2024-09-19 |
Showing 20 of 60. Sign in to see all of them.
Schizophrenia (30) · Psychotic Disorders (10) · Postoperative Nausea and Vomiting (7) · Depressive Disorder, Major (3) · Bipolar Disorder (2) · Depression (2) · Schizophrenia, Treatment-Resistant (2) · Acute Pain (1) · Anorexia Nervosa (1) · Anxiety Disorders (1) · Behavior, Addictive (1) · Chronic Pain (1) · Dementia (1) · Diabetes Mellitus (1) · Fibromyalgia (1)
Sanofi (6) · Acacia Pharma Ltd (5) · Shanghai Mental Health Center (5) · Central Institute of Mental Health, Mannheim (2) · Mclean Hospital (2) · Technical University of Munich (2) · University of Cologne (2) · All India Institute of Medical Sciences, Bhubaneswar (1) · Beersheva Mental Health Center (1) · Birte Glenthoj (1) · CHA University (1) · Chonbuk National University Hospital (1) · Fundación Pública Andaluza Progreso y Salud (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Geha Mental Health Center (1)
Germany (11) · China (9) · United States (7) · South Korea (4) · Spain (3) · Taiwan (3) · United Kingdom (3) · Denmark (2) · France (2) · Israel (2) · Switzerland (2) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1)
Alexander Grinshpoon, MD (1) · Anatoly Kreinin, MD, PhD (1) · Benedicto Crespo Facorro, Professor (1) · Birte Y Glenthoj, professor (1) · Biswa R Mishra, MD (1) · Boris B Quednow, Prof (1) · Chang-Yoon Kim, Prof. (1) · Chanoch Miodownik, MD (1) · Chao-Cheng Lin, M.D.,Ph.D. (1) · Ching-Hua Lin, MD, PhD (1) · Christian Keicher, Dr. med. (1) · Christian Schmidt-Kraepelin, Dr. (1) · Congze Wang (1)
PMID 31784354, PMID 11229973, PMID 12747876, PMID 15521794, PMID 16870959, PMID 20964499, PMID 22868877, PMID 23778382, PMID 28461752, PMID 28721051, PMID 28942738, PMID 29373756, PMID 29734953, PMID 30420252, PMID 30560750, PMID 30642415, PMID 33069317, PMID 33933719, PMID 33995015, PMID 34408155, PMID 34761749, PMID 35131596, PMID 35276079, PMID 36253804, PMID 37386462, PMID 37550314, PMID 38012795, PMID 38560960, PMID 38807685, PMID 38958149, PMID 40770798, PMID 42033308
2008 (1), R01MH068376 (1), R01MH095809 (1), R21MH120475 (1)